Prokidney (PROK) Interest Expenses (2021 - 2026)
Prokidney's (PROK) quarterly Interest Expenses came in at $1000.0 in Q2 2026, little changed year-over-year from $1000.0 in Q2 2025, and down 93.33% quarter-over-quarter from $15000.0 in Q1 2026.
Analysis
Prokidney (PROK) Interest Expenses (2021 - 2026) Analysis & Trends
Prokidney (PROK) has reported Interest Expenses for 6 consecutive years, with $1000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Interest Expenses changed 0.0% year-over-year to $1000.0 in Q2 2026; TTM through Jun 2026 was $19000.0, a 280.0% increase from a year earlier, with the FY2025 full-year figure at $4000.0, down 55.56% from the prior year.
- Interest Expenses was $1000.0 for Q2 2026 at Prokidney, down from $15000.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $170000.0 in Q2 2022 and troughed at $1000.0 in Q2 2025.
- A 5-year average of $15058.8 and a median of $2000.0 in 2022 frame the typical range for Interest Expenses.
- Across the five-year window, Interest Expenses surged 2800.0% in 2022 and sank 97.65% in 2023, its largest moves.
- Over 5 years, Interest Expenses stood at $2000.0 in 2022, then surged by 50.0% to $3000.0 in 2023, then plunged by 33.33% to $2000.0 in 2024, then slumped by 50.0% to $1000.0 in 2025, then changed by 0.0% to $1000.0 in 2026.
- The last three Interest Expenses figures came in at $1000.0 (Q2 2026), $15000.0 (Q1 2026), and $1000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 4.00 Bn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | -5.80 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 14.37 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 2.95 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 160,000.00 |
| 10 | Prokidney | 346.07 Mn | 346.07 Mn | - | 1,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,000.00 |
| Mar 31, 2026 | 15,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Mar 31, 2023 | 3,000.00 |
| Dec 31, 2022 | 2,000.00 |
| Sep 30, 2022 | 29,000.00 |
| Jun 30, 2022 | 170,000.00 |
| Mar 31, 2022 | 14,000.00 |
| Sep 30, 2021 | 1,000.00 |